Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Pediatric Infectious Disease Journal|September 27, 2014
Detection of vaccine-derived rotavirus strains in nonimmunocompromised children up to 3-6 months after RotaTeq® vaccinationJukka Markkula, Maria Hemming, Timo Vesikari
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 14, 2021
A major decrease in viral acute gastroenteritis in hospitalized Finnish children as rotavirus returns as the most detected pathogenOskari Pitkänen, Jukka Markkula, Maria Hemming-Harlo
The Pediatric Infectious Disease Journal|February 21, 2022
Sapovirus, Norovirus and Rotavirus Detections in Stool Samples of Hospitalized Finnish Children With and Without Acute GastroenteritisOskari Pitkänen, Jukka Markkula, Maria Hemming-Harlo
Vaccine|December 22, 2019
Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1Jukka Markkula, Maria Hemming-Harlo, Timo Vesikari
The Pediatric Infectious Disease Journal|July 26, 2016
Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in FinlandMaria Hemming-Harlo, Jukka Markkula, Leena Huhti, et al.
The Journal of Infection|October 4, 2019
Continuing rotavirus circulation in children and adults despite high coverage rotavirus vaccination in FinlandJukka Markkula, Maria Hemming-Harlo, Carita Savolainen-Kopra, et al.
Infectious Diseases (London, England)|January 10, 2017
Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderlyJukka Markkula, Maria Hemming-Harlo, Marjo T Salminen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Pageof 1